JP2018515623A5 - - Google Patents

Download PDF

Info

Publication number
JP2018515623A5
JP2018515623A5 JP2018512823A JP2018512823A JP2018515623A5 JP 2018515623 A5 JP2018515623 A5 JP 2018515623A5 JP 2018512823 A JP2018512823 A JP 2018512823A JP 2018512823 A JP2018512823 A JP 2018512823A JP 2018515623 A5 JP2018515623 A5 JP 2018515623A5
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
nhc
cancer
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2018512823A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018515623A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/033111 external-priority patent/WO2016187324A1/en
Publication of JP2018515623A publication Critical patent/JP2018515623A/ja
Publication of JP2018515623A5 publication Critical patent/JP2018515623A5/ja
Withdrawn legal-status Critical Current

Links

JP2018512823A 2015-05-18 2016-05-18 キナーゼ阻害剤としての複素環式化合物 Withdrawn JP2018515623A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562163369P 2015-05-18 2015-05-18
US62/163,369 2015-05-18
US201562203070P 2015-08-10 2015-08-10
US62/203,070 2015-08-10
PCT/US2016/033111 WO2016187324A1 (en) 2015-05-18 2016-05-18 Heterocyclic compounds as kinase inhibitors

Publications (2)

Publication Number Publication Date
JP2018515623A JP2018515623A (ja) 2018-06-14
JP2018515623A5 true JP2018515623A5 (cg-RX-API-DMAC7.html) 2019-06-27

Family

ID=57320732

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018512823A Withdrawn JP2018515623A (ja) 2015-05-18 2016-05-18 キナーゼ阻害剤としての複素環式化合物

Country Status (9)

Country Link
US (3) US10392402B2 (cg-RX-API-DMAC7.html)
EP (1) EP3297437A4 (cg-RX-API-DMAC7.html)
JP (1) JP2018515623A (cg-RX-API-DMAC7.html)
CN (1) CN107835637A (cg-RX-API-DMAC7.html)
AU (1) AU2016264220A1 (cg-RX-API-DMAC7.html)
CA (1) CA3024113A1 (cg-RX-API-DMAC7.html)
HK (1) HK1248070A1 (cg-RX-API-DMAC7.html)
IL (1) IL255750A (cg-RX-API-DMAC7.html)
WO (1) WO2016187324A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210069016A1 (en) * 2008-11-13 2021-03-11 Gholam A. Peyman Neurodegenerative Disorder Treatment Method
CN106573897B (zh) 2014-02-11 2019-09-24 拜耳制药股份公司 作为mIDH1抑制剂的苯并咪唑-2-胺
EP3105210B1 (en) 2014-02-11 2019-01-30 Bayer Pharma Aktiengesellschaft Benzimidazol-2-amines as midh1 inhibitors
HK1248070A1 (zh) * 2015-05-18 2018-10-12 转化药物开发有限责任公司 作为激酶抑制剂的杂环化合物
AU2020273376C1 (en) * 2016-10-24 2024-02-29 Translational Drug Development, Llc Amide compounds as kinase inhibitors, compositions and methods of treatment
WO2018094362A1 (en) 2016-11-21 2018-05-24 Translational Drug Development, Llc Heterocyclic compounds as kinase inhibitors
JP7490569B2 (ja) * 2018-04-24 2024-05-27 トランスレイショナル・ドラッグ・ディベロップメント・エルエルシー キナーゼ阻害剤としてのアミド化合物、組成物および処置方法
WO2020142745A1 (en) * 2019-01-04 2020-07-09 Translational Drug Development, Llc Methods of treating graft versus host disease and neoplastic disease with amide compounds
WO2021093795A1 (zh) * 2019-11-15 2021-05-20 武汉朗来科技发展有限公司 一种rock抑制剂及其制备方法和用途
CN113121443B (zh) 2019-12-31 2024-07-09 财团法人工业技术研究院 β-氨基酸衍生物、含其之激酶抑制剂与医药组合物以及其用途
MY206478A (en) * 2020-01-07 2024-12-18 Disarm Therapeutics Inc Inhibitors of sarm1
EP4192828A1 (en) * 2020-08-04 2023-06-14 Nura Bio, Inc. Substituted pyridine derivatives as sarm1 inhibitors
WO2022060812A1 (en) 2020-09-16 2022-03-24 Nura Bio, Inc. Substituted pyridine derivatives as sarm1 inhibitors
MX2024001322A (es) 2021-07-28 2024-04-30 Nura Bio Inc Derivados de piridina sustituida como inhibidores de sarm1.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8211919B2 (en) 2005-09-02 2012-07-03 Astellas Pharma Inc. Amide derivatives as rock inhibitors
EP2234486A4 (en) 2007-12-19 2011-09-14 Scripps Research Inst BENZIMIDAZOLES AND ANALOGS AS INHIBITORS OF RHO-KINASE
US20090258907A1 (en) * 2008-04-09 2009-10-15 Abbott Laboratories Compounds useful as inhibitors of rock kinases
US20130129677A1 (en) * 2009-02-27 2013-05-23 Siga Technologies, Inc. Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections
AR078793A1 (es) * 2009-10-27 2011-12-07 Orion Corp Derivados de carboxamidas no esteroidales y acil hidrazona moduladores de receptores androgenicos de tejido selectivo (sarm), composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento del cancer de prostata entre otros
US9221808B2 (en) * 2010-04-16 2015-12-29 H. Lee Moffitt Cancer Center And Research Institute, Inc. Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinase (ROCK) and methods of use
US8697911B2 (en) * 2010-07-07 2014-04-15 Boehringer Ingelheim International Gmbh Rho kinase inhibitors
EP2702055A1 (en) * 2011-04-11 2014-03-05 Nerviano Medical Sciences S.r.l. Pyrazolyl-pyrimidine derivatives as kinase inhibitors
HK1248070A1 (zh) * 2015-05-18 2018-10-12 转化药物开发有限责任公司 作为激酶抑制剂的杂环化合物

Similar Documents

Publication Publication Date Title
JP2018515623A5 (cg-RX-API-DMAC7.html)
KR101937501B1 (ko) 치환된 2,3-디히드로이미다조[1,2-c]퀴나졸린 염
CN103717604B (zh) 取代的氨基咪唑并哒嗪
CN103687858B (zh) 作为mknk1激酶抑制剂的氨基取代的咪唑并哒嗪
TWI556820B (zh) Hsp90抑制劑之組合
JP2021507900A5 (cg-RX-API-DMAC7.html)
JP2021508686A5 (cg-RX-API-DMAC7.html)
JP6173426B2 (ja) アミノ置換イミダゾピリダジン
JP6147761B2 (ja) アミノ置換イミダゾピリダジン
RU2017122824A (ru) Пирролопиримидиновое соединение
ES2646916T3 (es) Aminoimidazopiridazinas como inhibidores de MKNK1 cinasa
CN110582489A (zh) Rho相关蛋白激酶抑制剂、包含其的药物组合物及其制备方法和用途
CN110573501A (zh) Rho相关蛋白激酶抑制剂、包含其的药物组合物及其制备方法和用途
PH12018500765B1 (en) N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
JP2017532360A5 (cg-RX-API-DMAC7.html)
JP2019518766A5 (cg-RX-API-DMAC7.html)
JP2017520607A5 (cg-RX-API-DMAC7.html)
JP2020517616A5 (cg-RX-API-DMAC7.html)
CN103958515A (zh) 氨基取代的咪唑并哒嗪
JP2017526677A5 (cg-RX-API-DMAC7.html)
JPWO2019126086A5 (cg-RX-API-DMAC7.html)
MX2018004364A (es) Acidos pirazolo [3,4-b] piridin-6-carboxilicos sustituidos y su uso.
JP2018529745A5 (cg-RX-API-DMAC7.html)
JP2019512535A5 (cg-RX-API-DMAC7.html)
JP2020502066A5 (cg-RX-API-DMAC7.html)